Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain
In this cohort study, participation in NYS's medical cannabis program was associated with reduced prescription opioid receipt during 18 months of prospective follow-up, accounting for unregulated cannabis use.
Authors
- Yuval Zolotov (ORCID: https://orcid.org/0000-0002-5391-7379)
- Yuting Deng (ORCID: https://orcid.org/0000-0001-6007-1482)
- Joanna L. Starrels (ORCID: https://orcid.org/0000-0002-1865-1966)
- Deepika E. Slawek (ORCID: https://orcid.org/0000-0001-8403-8433)
- Julia Hope Arnsten (ORCID: https://orcid.org/0000-0002-7741-1567)
- Haruka Minami (ORCID: https://orcid.org/0000-0002-0169-0459)
- Stephen Dahmer (ORCID: https://orcid.org/0000-0002-3606-0289)
- Jonathan Ross (ORCID: https://orcid.org/0000-0001-6126-3048)
- Chenshu Zhang (ORCID: https://orcid.org/0000-0002-3233-3905)
- FRANCES RUDNICK LEVIN (ORCID: https://orcid.org/0000-0003-4209-1329)
- Nancy Sohler (ORCID: https://orcid.org/0000-0003-3147-1297)
- Chinazo O Cunningham
- Giovanna Calderon DiFrancesca
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- University of Arizona (US)
- Fordham University (US)
- City University of New York (US)
- Columbia University Irving Medical Center (US)
- New York State Psychiatric Institute
- Ariel University (IL)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1001/jamainternmed.2025.6496
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- City University of New York
- National Institutes of Health
- Center for AIDS Research, University of Washington
- National Institute on Aging
- National Heart, Lung, and Blood Institute
- National Institute of Mental Health
- National Institute on Drug Abuse
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases